Piper Jaffray downgrades MannKind (Nasdaq:MNKD) from Neutral to Underweight and slashes its price target from $5 down to $1.50 MannKind Corporation (NASDAQ:MNKD) stock opened today at $4.44 and is currently trading at $3.85. The stock showed a negative weekly performance of -17.72%.
Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) sank 70.49% early Monday after the Australian drug developer said its most advanced potential treatment failed to meet the main goal in a study of patients with Alzheimer’s disease. Prana said Alzheimer’s patients taking its treatment, labeled PBT2, failed to have a statistically significant reduction in levels of brain plaque against those who took a placebo or fake drug, according to early results from a midstage study. Prana Biotechnology Limited (ADR) (NASDAQ:PRAN) stock opened at $3.01, in current trading session and currently is at $2.83, by loosing -71.29%.The 52 week range of $2.12-$13.29.Company’s market capitalization is $117.03 million.
Idera Pharmaceuticals Inc (NASDAQ:IDRA) reported positive top line data from its randomized, double blind, placebo leveraged Phase II trial of IMO-8400 in as many as 32 patients suffering from moderate to severe plaque psoriasis. Idera Pharmaceuticals Inc (NASDAQ:IDRA) stock is currently trading at $4.27 .The EPS of the stock is -0.64. Company’s market capitalization is $350.85 million.
Stock analysts at RBC Capital started coverage on shares of Arrowhead Research Corp (NASDAQ:ARWR) in a report issued on Tuesday, Analyst Ratings News reports. The firm set an “outperform” rating on the stock. Arrowhead Research Corp (NASDAQ:ARWR) stock opened the session at $15.45, and now is at $16.46. The 52 week range of the ARWR stock remained $1.65-$27.63 and the day range was $15.20-$16.47.
Leave a Reply